23andMe built information in 2018 when it announced a $three hundred million, four-calendar year offer to deliver pharma large GlaxoSmithKline access to its prospects’ genetic info. The initial drugs the two organizations are focusing on jointly is definitely an anti-cancer antibody, a spokesperson for 23andMe stated in September 2020. https://affordable-divorce-attorn44211.ssnblog.com/3889412/5-essential-elements-for-dna-testing-in-new-york